Latest News for: calcium

Edit

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium ...

The Huntsville Item 19 Mar 2025
Updated top-line results demonstrate improved outcomes in adults with narcolepsy or idiopathic hypersomnia treated with Xywav as observed in the Phase 4 DUET (Developing Understanding of Hypersomnia ...
Edit

16 Calcium-Rich Foods For Stronger Bones And Better Overall Health

Vogue 19 Mar 2025
And while you can easily increase your calcium intake with supplements, Dieras notes that a balance is required – and that too much of the nutrient can lead to an increased risk of prostate cancer and heart disease ... What does calcium do for you?.
Edit

15 Calcium-Rich Foods for Stronger Bones and Health Over

Vogue 19 Mar 2025
One can’t think of calcium without thinking of milk ... Dieras also lists cereals as another source of calcium ... 100 g of white beans contain 236 mg of the nutrient and even 100 g of chickpeas contain 111 mg of calcium.What does calcium do for you?.
Edit

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

PR Newswire 19 Mar 2025
About Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solutionXywav is the only low-sodium oxybate approved by the U.S ... Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution.
Edit

Eneboparatide met primary endpoint of normalising serum calcium in adults with hypoparathyroidism at 24 weeks in CALYPSO Phase III trial

Pharmiweb 17 Mar 2025
The primary endpoint is a composite of normalisation of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy ... calcium and phosphate levels in the blood.
Edit

Eneboparatide met primary endpoint of normalizing serum calcium in adults with hypoparathyroidism at 24 weeks in CALYPSO Phase III trial (AstraZeneca Pharmaceuticals LP)

Public Technologies 17 Mar 2025
The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy ... calcium and phosphate levels in the blood.
×